IART
INTEGRA LIFESCIENCES HOLDINGS CORP
NASDAQ · Healthcare · Medical - Devices · US
$12.75
−0.62%Oct 23, 2026, 13:00 UTC
Law Offices of Howard G. Smith said it is conducting a securities-fraud investigation into whether INTEGRA LIFESCIENCES HOLDINGS CORP violated federal securities laws.
Source:Oct 22, 2026, 16:14 UTC
Law Offices of Frank R. Cruz announced an investigation into potential securities fraud claims involving INTEGRA LIFESCIENCES HOLDINGS CORP.
Source:Oct 21, 2026, 12:26 UTC
INTEGRA LIFESCIENCES HOLDINGS CORP reported quarterly earnings of $0.59 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $0.56 per share.
Source:Oct 21, 2026, 10:00 UTC
INTEGRA LIFESCIENCES HOLDINGS CORP reported financial results for the third quarter ended September 30, 2026.
Source:Oct 19, 2026, 20:05 UTC
INTEGRA LIFESCIENCES HOLDINGS CORP closed a private offering of $450.0 million in aggregate principal amount of 9.500% senior secured notes due 2033.
Source:Oct 5, 2026, 12:06 UTC
Johnson Fistel, PLLP announced it is investigating Integra LifeSciences Holdings Corporation on behalf of investors who may have suffered losses following flooding-related outlook cuts and a 21% stock decline.
Source:Oct 2, 2026, 22:42 UTC
SueWallSt notified investors of a pending investigation into potential securities claims against Integra LifeSciences on behalf of shareholders who lost money after the company's preliminary third-quarter revenue fell $4.3 million to $6.3 million short of Wall Street estimates.
Oct 2, 2026, 12:05 UTC
Integra LifeSciences Holdings Corporation reported preliminary unaudited third quarter results and updated its full-year 2026 guidance.
Oct 2, 2026, 12:00 UTC
Integra LifeSciences Holdings Corporation launched a proposed $600 million seven-year Senior Secured Term Loan B as part of a broader refinancing transaction.
Source:Sep 29, 2026, 12:30 UTC
Integra LifeSciences announced that the 100th patient has been enrolled in its AERA Pediatric Registry, a prospective multicenter registry targeting 300 pediatric patients.
Source:Jul 29, 2026, 10:00 UTC
Integra LifeSciences Holdings Corporation reported financial results for the second quarter ending June 30, 2026.
Jun 23, 2026, 12:00 UTC
Integra LifeSciences announced several leadership appointments within its commercial organization.
Source: